Xolair

Oct 20, 2025

Peanut allergy is among the most common and serious types of food allergy, with prevalence increasing over the past few decades, particularly among younger populations. It usually first appears in childhood, with symptoms emerging as early as 4 months of age and most often within the first two years of life. Around...

Mar 01, 2024

Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...